Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Importancia del tratamiento multidisciplinario de las tumoraciones ováricas en adolescentes. A propósito de un caso

Multidisciplinary management of ovarian tumors in adolescents. A case report.

Ginecol Obstet Mex. 2019 noviembre;87(11):762-768.

https://doi.org/10.24245/gom.v87i11.3302

Lourdes Gabasa-Gorgas,1 Beatriz Procas-Ramón,2 Sara Ruíz-Martínez,3 Cristina Hierro-Espinosa,3 Laura Polo-Oliveros,3 Fernando Roldán-Rivas3         

1 Hospital Universitario Miguel Servet, Zaragoza, España.
2 Hospital Ernest Lluch, Calatayud, España.
3 Hospital Clínico Universitario Lozano Blesa; Zaragoza, España.


Corrrespondencia:

Lourdes Gabasa Gorgas L
lourdesgabasa@gmail.com

Debe citarse como:

Gabasa-Gorgas L, Procas-Ramón B, Ruíz-Martínez S, Hierro-Espinosa C, Polo-Oliveros L, Roldan-Rivas F. Importancia del tratamiento muldisciplinario de las tumoraciones ováricas en adolescentes. A propósito de un caso. Ginecol Obstet Mex. 2019 noviembre;87(11):762-768. https://doi.org/10.24245/gom.v87i11.3302

Resumen

ANTECEDENTES: Las masas anexiales pueden encontrarse en mujeres de cualquier edad y ser benignas o malignas. El tratamiento varía según el tipo de masa, por lo que es importante establecer el diagnóstico diferencial correcto, sobre todo en mujeres jóvenes en quienes las cirugías radicales tendrán importante repercusión en la fertilidad futura.

CASO CLÍNICO: Paciente de 19 años, que consultó por dolor abdominal. En la ecografía se apreció una masa abdominal voluminosa en el hipogastrio, heterogénea, al parecer dependiente del ovario. La TAC confirmó una masa de 14 cm, con signos sospechosos de malignidad; los marcadores tumorales reportaron elevación de AFP. La laparotomía exploradora, con biopsia intraoperatoria, informó un tumor de células germinales. Se decidió la cirugía conservadora, en virtud de la edad de la paciente. Antes de iniciar la quimioterapia se llevó a cabo la criopreservación de ovocitos, como técnica de preservación de la fertilidad. En la actualidad, la paciente permanece en controles seriados y libre de enfermedad.

CONCLUSIONES: El hallazgo de una masa anexial en una adolescente requiere un estudio exhaustivo para establecer el diagnóstico correcto; en ocasiones, estas masas son malignas y requieren acceso quirúrgico. Es importante que la cirugía sea conservadora para ofrecer la posibilidad de preservar la fertilidad.

PALABRAS CLAVE: Adolescente; preservación de la fertilidad; tumor de células germinales; laparotomía, criopreservación.

Abstract

BACKGROUND: An adnexal mass can be found in women at any age, and be both benign and malignant. The management varies according to the type of mass, therefore it is important to make a correct differential diagnosis, moreover in young women in which radical surgeries will have a great impact on future fertility.

CLINICAL CASE: We report a case of a 19-year-old woman who consulted for abdominal pain. In ultrasound, the presence of a large, heterogeneous hypogastric abdominal mass appears to depend on the ovary. The study was completed by performing a CT scan that confirmed the presence of a mass of 14 cm, with suspicious signs of malignancy. Tumor markers were requested, highlighting the elevation of AFP. With these findings, an exploratory laparotomy was performed with an intraoperative biopsy that reported a germ cell tumor or Yolk Sac tumor. A conservative surgery was performed given the age of the patient and prior to initiating chemotherapy treatment, oocyte cryopreservation was carried out as a fertility preservation technique. Currently the patient follows serial controls and is free of disease.

CONCLUSIONS: Finding an adnexal mass in a teenager, requires a thorough study to reach a correct diagnosis, sometimes these masses are malignant and require surgical approach. It is important to perform conservative surgery whenever possible and offer the possibility of preserving fertility.

KEYWORDS: Adolescent; Fertility preservation; Endodermal sinus tumor; Yolk Sac Tumor; Laparotomy; Cryopreservation.

    1. Nasioisdis D, et al. Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base. Gynecol Oncol. 2017 Nov; 147 (2): 296-301. doi: 10.1016/j.ygyno.2017.08.013
    2. Faure Concer C, et al. Ovarian Yolk Sac Tumors; Does Age Matter? Int J Gynecol Cancer. 2018 Jan; 28 (1): 77-84. doi: 10.1097/IGC.0000000000001149.
    3. Inada Y, et al. Rapidly growing juvenile granulosa cell tumor of the ovary arising in adult: a case report and review of the literature. J Ovarian Res. 2018 Dec 14; 11 (1): 100. doi: 10.1186/s13048-018-0474-0.
    4. Agarwal R, et al. A retrospective analysis of the pattern of care and survival in patients with malignant ovarian germ cell tumors. South Asian J Cancer. 2019; 8 (1): 35-40. doi: 10.4103/sajc.sajc_6_18.
    5. Euscher ED. Germ Cell Tumors of the Female Genital Tract. Surg Pathol Clin. 2019; 12 (2): 621-49. doi: 10.1016/j.path.2019.01.005.
    6. Chen LH, et al. Yolk Sac Tumor in an Eight-Year-Old Girl: A Case Report and Literature Review. Front Pediatr. 2019; 7:1 69. doi: 10.3389/fped.2019.00169
    7. Kollmannsberger CK, et al. Management of Stage II Germ Cell Tumors: Be Sure, Be Patient, Be Safe. J Clin Oncol. 2019 Jun 10. doi: 10.1200/JCO.19.00502.
    8. Luh LCPN, et al. Management comprehensive multidisciplinary of malignant ovarian germ cell tumors and feto - maternal outcome: A case series report and literature review. Maced J Med Sci. 2019 Apr 3; 7 (7): 1174-79. doi: 10.3889/oamjms.2019.251
    9. Lavazzo C, et al. Is fertility sparing surgery a treatment option for young patients with yolk sac tumor? Minerva Ginecol. 2018 Dec; 70 (6): 750-53. doi: 10.23736/S0026-4784.18.04194-1.
    10. Nasioudis D, et al. Fertility-preserving surgery for advanced stage ovarian germ cell tumors. Gynecol Oncol. 2017; 147 (3): 493-96. doi: 10.1016/j.ygyno.2017.10.010
    11. Park JY, et al. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors. Gynecol Oncol. 2017; 145 (3): 513-18. doi: 10.1016/j.ygyno.2017.03.023
    12. Turkmen O, et al. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors. J Adolesc Young Adult Oncol. 2017;6 (2): 270-6. doi: 10.1089/jayao.2016.0086.
    13. Makris GM, et al. Giving Birth After Fertility Sparing Treatment for a Yolk Sac Tumour: Case Report. J Clin Diagn Res. 2017 Aug; 11 (8): QD12-QD13. doi: 10.7860/JCDR/2017/25820.10524
    14. Dunn TN, et al. Successful yolk-sac tumor treatment with fertility-sparing partial oophorectomy. Gynecol Oncol Rep. 2018 Nov 30; 27: 22-24. doi: 10.1016/j.gore.2018.11.007.
    15. Qin B, et al. Are omentectomy and lymphadenectomy necessary in patients with apparently early-stage malignant ovarian germ cell tumors?. Int J Gynecol Cancer. 2019. doi: 10.1136/ijgc-2018-000078.
    16. Li J, Wu X. Current strategy for the treatment of ovarian germ cell tumors: Role of extensive Surgery. Curr Treat Options Oncol. 2016; 17 (8): 44. doi: 10.1007/s11864-016-0416-2.
    17. Park JY, et al. Outcomes of surgery alone and surveillance strategy in young women with stage I malignant ovarian germ cell tumors. Int J Gynecol Cancer. 2016; 26 (5): 859-64. doi: 10.1097/IGC.0000000000000702
    18. Satoh T, et al. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour. Eur J Cancer. 2015; 51 (3): 340-51. doi: 10.1016/j.ejca.2014.12.004
    19. Zhang GY, et al. Neoadjuvant bleomycin, etoposide, and cisplatin (BEP) chemotherapy in the treatment of extensively advanced yolk sac tumors: A single center experience. Int J Gynecol Cancer. 2018 May; 28 (4): 713-20. doi: 10.1097/IGC.0000000000001209.
    20. Newton C, et al. A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice. Eur J Cancer. 2019; 113: 19-27. doi: 10.1016/j.ejca.2019.03.001.
    21. De La Motte RT, et al. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor. Ann Oncol. 2008; 19 (8): 1435-41. doi: 10.1093/annonc/mdn162
    22. Satoh T, et al. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour. Eur J Cancer. 2015; 51 (3): 340-51. doi: 10.1016/j.ejca.2014.12.004.
    23. Chatchotikawong U, et al. 8-year analysis of the prevalence of lymph nodes metastasis, oncologic and pregnancy outcomes in apparent early-stage malignant ovarian germ cell tumors. Asian Pac J Cancer Prev. 2015; 16 (4): 1609-13.

Comentarios